title: Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study).
abstract: BACKGROUND
  The Metabolic syndrome is considered to be an important public health problem, but few epidemiological studies have defined the present situation in France. EPIMIL is a prospective epidemiological study that began on February 1, 2003.
  
  
  METHODS
  This study was designed to identify the clinical and laboratory parameters of metabolic syndrome and cardiovascular risk factors in a population of 2045 male military personnel based in the Paris region. The initial 1-year cross-sectional study will be followed by a 10-year follow-up and patient care.
  
  
  RESULTS
  The 2045 subjects included 185 (9%) presented at least 3 of the 5 NCEP ATP III criteria defining metabolic syndrome. They were significantly older (42.2 +/- 8.5 yrs) than the other subjects (37.3 +/- 8.7 yrs, P<0.001), had a higher BMI (29.5 +/- 3.4 vs 24.8 +/- 2.9 kg/m2, P<0.001) and a greater body weight at age 20 (75.4 +/- 11 vs 70.4 +/- 8.5 kg, P<0.01). Smoking, little physical activity and family histories of diabetes and arterial hypertension were more frequent in these men. While levels of the cholesterol and CRP us were higher, Lp(a) and homocysteine concentrations were normal. Plasma insulin and BMI (r = 0.456 P<0.0001) and plasma insulin and waist circumference (r = 0.446 P<0.0001) were well correlated. Lastly, plasma insulin, free fatty acids and cardiovascular risk increased steadily with the increase in the number of metabolic syndrome criteria.
  
  
  CONCLUSIONS
  These results in a large and particularly uniform population of men show the prevalence of metabolic syndrome in adult men, and demonstrate its link with insulin resistance. Men with several risk factors require specific care, particularly for hypertension and dyslipidemia; the effectiveness of this care will be evaluated during the follow-up period.
authors.affiliation: Service d'Endocrinologie, hôpital d'Instruction des Armées Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France. bernard.bauduceau@wanadoo.fr
authors.forename: B
authors.initials: B
authors.lastname: Bauduceau
authors.forename: F
authors.initials: F
authors.lastname: Baigts
authors.forename: L
authors.initials: L
authors.lastname: Bordier
authors.forename: P
authors.initials: P
authors.lastname: Burnat
authors.forename: F
authors.initials: F
authors.lastname: Ceppa
authors.forename: V
authors.initials: V
authors.lastname: Dumenil
authors.forename: O
authors.initials: O
authors.lastname: Dupuy
authors.forename: J P
authors.initials: JP
authors.lastname: Le Berre
authors.forename: H
authors.initials: H
authors.lastname: Mayaudon
authors.forename: S
authors.initials: S
authors.lastname: Paillasson
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000453:epidemiology; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D049628:Body Size; D002318:Cardiovascular Diseases / Q000453:epidemiology; D003430:Cross-Sectional Studies; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D008875:Middle Aged; D008889:Military Personnel / Q000706:statistics & numerical data*; D009765:Obesity / Q000453:epidemiology; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood; D014944:World Health Organization
chemical_list: D001786:Blood Glucose; D014280:Triglycerides